Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Olivier te Boekhorst
Olivier te Boekhorst is recorded as CEO and Board Member at Immucell Corp /De/ (ICCC). Immucell Corp /De/ reported in an 8-K filed November 4, 2025 that Olivier te Boekhorst was appointed director, effective October 29, 2025. Immucell Corp /De/ reported in an 8-K filed November 4, 2025 that Olivier te Boekhorst was appointed President and CEO, effective November 1, 2025. Immucell Corp /De/ reported in an 8-K filed September 30, 2025 that Olivier te Boekhorst was appointed President and Chief Executive Officer, effective November 1, 2025. Olivier te Boekhorst has spoken on 2 earnings calls across 1 company, most recently for Immucell Corp /De/ on August 14, 2026.
“At its meeting on October 29, 2025, the Company’s Board of Directors appointed Mr. te Boekhorst to the Board of Directors along with Timothy C. Fiori, CFO.”
Immucell Corp /De/ Form 8-K, filed November 4, 2025
· Read the filing
“Effective November 1, 2025, Olivier te Boekhorst began serving as President and CEO of the Company, succeeding Michael F. Brigham.”
Immucell Corp /De/ Form 8-K, filed November 4, 2025
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
